Injury risk; stem-cell start; food faces
People with autism are at high risk of death from injury, China starts a clinical trial involving human embryonic stem cells, and individuals with autism have trouble seeing faces in food.
A roundup of autism papers and media mentions you may have missed.
People with autism are at high risk of death from injury, China starts a clinical trial involving human embryonic stem cells, and individuals with autism have trouble seeing faces in food.
The British government is limiting the number of new autism diagnoses in the United Kingdom, CRISPR makes the mistake everyone worried it would, and Minnesota imams reach out amid a measles outbreak.
Proposed cuts to biomedical research in the United States spark outrage, the autism research community has lost a legend in Isabelle Rapin, and scientists like to move around.
A doctor decodes a rare genetic condition, burnout is a big problem in science, and an actor with autism will play the lead in “The Curious Incident of the Dog in the Night-Time.”
Autism researchers and advocates gather in San Francisco, nearly one-third of drugs approved in the United States are later linked to safety issues, and an interactive map lays out locations of U.S. autism clinics.
The National Institutes of Health receives a $2 billion boost, politicians who propagate anti-vaccine views are fueling outbreaks, and a new report highlights preventable conditions associated with autism.
Scott Gottlieb is poised to become chief of the U.S. Food and Drug Administration, neuroscience research has blossomed over the past decade, and new grants support adults with autism.
The March for Science is finally here, the scientific workforce is aging at an alarming rate, and a pint-size podcaster tackles serious science.
Researchers captured networks of neurons lighting up in a small aquatic animal, facial recognition software can flag genetic conditions, and a Muppet with autism makes her debut on “Sesame Street.”
Cell Press announces its new preprint server, Donald Trump has yet to name a science advisor, and new gene-editing tools are calling an old finding into question.